ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy
Clinical trial NCT07218887 · RECRUITING
Trial details
- NCT number
- NCT07218887
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-24
- Primary completion
- 2032-01-27
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.